Q&A: AstraZeneca Execs Talk Immunotherapy Strategy And More At ASCO
Executive Summary
Chief Medical Officer Briggs Morrison and Senior VP for Oncology Global Portfolio and Product Strategy Mondher Mahjoubi sat down with “The Pink Sheet” to discuss the firm’s oncology strategy and outlook, including the choices it’s making with immuno-oncology, the valuation of the oncology franchise and the climate for cancer drug prices.